Profile
Paul R.
McGuirk is currently Director, Chief Development Officer & Executive VP at Gardiner Healthcare Acquisitions Corp.
since 2021.
He is Chief Development Officer & Executive VP at Gardiner Founder LLC.
He is an Authorized Member at PRM Pharmaceuticals LLC.
Formerly, Dr. McGuirk was Executive Director at Chemical Technologies, Inc. He was Chief Technology Officer, Director & EVP at Aeromics, Inc. from 2009 to 2020.
He was Manager-Infectious Diseases Medicinal Chemistry at Pfizer Inc. from 1982 to 2009.
Paul R. McGuirk active positions
| Companies | Position | Start |
|---|---|---|
| GARDINER HEALTHCARE ACQUISITIONS CORP. | Director/Board Member | 01/04/2021 |
PRM Pharmaceuticals LLC | Corporate Officer/Principal | - |
Gardiner Founder LLC | Corporate Officer/Principal | - |
Former positions of Paul R. McGuirk
| Companies | Position | End |
|---|---|---|
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Chief Tech/Sci/R&D Officer | 01/11/2020 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2009 |
Chemical Technologies, Inc.
Chemical Technologies, Inc. Contract DrillingIndustrial Services Provides retail drilling fluids services | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Chemical Technologies, Inc.
Chemical Technologies, Inc. Contract DrillingIndustrial Services Provides retail drilling fluids services | Industrial Services |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Operates preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema in stroke | Health Technology |
Gardiner Healthcare Acquisitions Corp.
Gardiner Healthcare Acquisitions Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Gardiner Founder LLC | |
PRM Pharmaceuticals LLC |
- Stock Market
- Insiders
- Paul R. McGuirk
















